Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

AMILORIDE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE

AMILORIDE HYDROCHLORIDE; HYDROCHLOROTHIAZIDE

Standard Dose
EQ 5MG ANHYDROUS;50MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview AMILORIDE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE is listed in Drugs@FDA under application 073357 (ANDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient AMILORIDE HYDROCHLORIDE; HYDROCHLOROTHIAZIDE Form and strength TABLET;ORAL - EQ 5MG ANHYDROUS;50MG Sponsor CHARTWELL RX Submission history Latest submission status date: 2020-08-20 00:00:00.

Structured Monograph

Clinical summary

Approval overview AMILORIDE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE is listed in Drugs@FDA under application 073357 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient AMILORIDE HYDROCHLORIDE; HYDROCHLOROTHIAZIDE Form and strength TABLET;ORAL - EQ 5MG ANHYDROUS;50MG Sponsor CHARTWELL RX Submission history Latest submission status date: 2020-08-20 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.
AMILORIDE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE (AMILORIDE HYDROCHLORIDE; HYDROCHLOROTHIAZIDE) | Drug Monograph | MedicHelpline